Stay updated on Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page.

Latest updates to the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page’s revision/version number was updated from v3.5.2 to v3.5.3, reflecting a frontend or release update rather than a change to the clinical trial information.SummaryDifference0.1%

- Check22 days agoChange Detected- Revision: v3.5.2 updated from the previous v3.5.0.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check86 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page shows Revision: v3.4.1, replacing v3.4.0; no changes to study content or functionality are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check100 days agoChange DetectedThese changes are limited to UI and metadata, including a glossary option, minor capitalization/wording in QC labels, and revision/version information, with no impact on core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial page.